Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 13 May 2009, doi:10.1136/bmj.b1973
Cite this as: BMJ 2009;338:b1973
Rebecca Coombes
1 BMJ
| The first 150 words of the full text of this article appear below. |
Seriously ill patients who choose to top up their NHS care by buying additional drugs for treatment at the end of life are likely to be treated on the same ward as patients who cant afford the extra drugs, MPs warned this week.
Since November 2008 a change of rules has allowed patients to buy additional drugs without losing their right to NHS care—as long as these drugs are administered separately from NHS treatment. The change came after an increasing number of challenges to the NHS by patients to provide new unapproved drugs to treat cancer and other life threatening conditions.
But in its report on top-up payments this week, MPs from the health select committee said that the government had fudged the issue. "We are very concerned that separation will be hard to achieve in practice," they said.
"We believe it would be wrong for very seriously ill patients
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?